Mucormycosis: An opportunistic pathogen during COVID-19

I Mahalaxmi, K Jayaramayya, D Venkatesan… - Environmental …, 2021 - Elsevier
The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend.
The second wave of this disease has led to panic in many countries, including India and …

The Triple Crown: NO, CO, and H2S in cancer cell biology

PP Oza, K Kashfi - Pharmacology & Therapeutics, 2023 - Elsevier
Nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S) are three
endogenously produced gases with important functions in the vasculature, immune defense …

Eugenol: A novel therapeutic agent for the inhibition of Candida species infection

M Didehdar, Z Chegini, A Shariati - Frontiers in Pharmacology, 2022 - frontiersin.org
The high occurrence and mortality rates related to candidiasis emphasize the urgent need to
introduce new therapeutic approaches to treat this infection. Eugenol, the main phenolic …

Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: a systematic review of case reports and case series

Z Chegini, M Didehdar, A Khoshbayan, S Rajaeih… - Mycoses, 2020 - Wiley Online Library
Background Patients with diabetes are known as an important high‐risk group for cerebral
mucormycosis (CM). Method We conducted a structured search using PubMed/MEDLINE to …

[HTML][HTML] The aerobiome in a hospital environment: Characterization, seasonal tendencies and the effect of window opening ventilation

A Núñez, AM García - Building and Environment, 2023 - Elsevier
The urban atmosphere carries biological particles (bioaerosols) that may cause several
diseases and allergies. These bioaerosols infiltrate and mix with those present inside the …

Cinnamomum: The New Therapeutic Agents for Inhibition of Bacterial and Fungal Biofilm-Associated Infection

M Didehdar, Z Chegini, SP Tabaeian… - Frontiers in Cellular …, 2022 - frontiersin.org
Due to the potent antibacterial properties of Cinnamomum and its derivatives, particularly
cinnamaldehyde, recent studies have used these compounds to inhibit the growth of the …

Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions

A Tragiannidis, A Gkampeta, M Vousvouki… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Invasive fungal infections continue to be important causes of morbidity and
mortality in severely ill and immunocompromised patient populations. The past three …

Emerging fungal infections

A Spallone, IS Schwartz - Infectious Disease Clinics, 2021 - id.theclinics.com
With an ever-expanding cohort of immunocompromised patients at risk of opportunistic
infections from an endless spectrum of biologically diverse fungal pathogens, medical …

Effect of Amphotericin B on the thermodynamic stability, aggregation state, hemolysis and antifungal activity of Amphotericin B-nonionic surfactant micellar system

L Liu, Z Liang, Y Zhou, H Pan, H Liu - Journal of Molecular Liquids, 2023 - Elsevier
Amphotericin B (AmB) is a toxic and low solubility antifungal drug. In this paper, AmB was
encapsulated by different nonionic surfactants and the effect of their structures on AmB was …

Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis

JP Lynch III, MC Fishbein, F Abtin… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction Mucormycosis (MCR) is caused by filamentous molds within the Class
Zygomycetes and Order Mucorales. Infections can result from inhalation of spores into the …